The 2023 First Quarter Economic Operation Analysis Meeting of Shoujian Technology Co., Ltd. Successfully Held

The 2023 first quarter economic operation analysis meeting of Shoujian Technology Co., Ltd. was held on the afternoon of April 18th in the west conference room on the first floor of the company. Shen Xiaofeng, Chairman of Shoujian Technology, Li Jianjun, Vice Chairman, Li Ke, General Manager, and representatives of various departments and employees attended the meeting. The group leaders were also specially invited to attend the meeting.

At the meeting, the leaders in charge of each department of the company reported on the key work, target completion status, highlights and main problems in the first quarter of 2023, and elaborated on the next steps of work ideas and goals. In order to focus on the goals, Li Ke signed a 2023 performance target responsibility letter with the executives in charge of each section.

Li Ke summarized and reviewed the work of Shoujian Technology in the first quarter. He gave full recognition to the work of various departments, and at the same time, there was a widespread severe price drop in the market, which led to a decline in economic data in the first quarter. However, he also emphasized that this should not be an excuse for us, but rather a challenge. We should assess the situation, observe ourselves better, and be prepared for the future.

Li Ke emphasized that the company has formed a consensus on serving customers, and cross departmental cooperation has greatly developed, which is an important progress in the company's transformation. In the context of a sluggish external market environment, the market and production have identified breakthrough points and spontaneously made improvements, demonstrating the joint efforts and goal awareness of all employees.

In terms of the maximum value of pharmaceutical factories, Li Ke stated that the company applies the fastest speed, highest efficiency, best quality, and lowest cost to deliver products. For orders processed on behalf of others, he proposed higher requirements for production systems and production service supporting systems.

The next focus of work is to improve efficiency, lean production, transform planned production into order based production delivery mode, and solidify standardized operation ideas and methods.

In addition, he particularly emphasized the word 'fast', which means that the construction of a synthesis plant should be fast. Similarly, the overall reform plan of pharmaceutical factories must also be fast, because time waits for no one, and the market will not pity them. Only by being sensitive and responsive can we seize the favorable opportunity.

Finally, Li Ke encourages all employees to closely adhere to their goals, gather strength, and explore the market, in order to achieve the company's development and continuous progress. This is an inspiring call and also a confidence and expectation for the company's future.